Association of NOTCH4 and CYP2E1 Genetic Variants With Schizophrenia in the Bangladeshi Population: A Case-Control Study
- PMID: 39698532
- PMCID: PMC11652386
- DOI: 10.1002/hsr2.70262
Association of NOTCH4 and CYP2E1 Genetic Variants With Schizophrenia in the Bangladeshi Population: A Case-Control Study
Abstract
Background and aims: Schizophrenia (SCZ) is among the most persistent and devastating psychological problems. Different genetic polymorphisms are responsible for the predisposition of SCZ, and we screened NOTCH4 (rs2071287, rs204993) and CYP2E1 (rs2070673) polymorphisms in this study to find the connection with SCZ development.
Methods: We investigated a total of 420 samples (210 patients and 210 controls) and used the PCR-RFLP technique to genotype all SNPs. For statistical analyses, SPSS (version 25.0) was applied.
Results: In the case of NOTCH4 rs2071287, no evidence of a link was found in any genetic models, whereas NOTCH4 rs204993 and CYP2E1 rs2070673 showed a significant linkage in four genetic models with SCZ risk (for NOTCH4 rs204993, additive model 2: OR = 3.39, CI = 1.84-6.23, p = 0.0001; dominant: OR = 1.84, CI = 1.22-2.76, p = 0.0032; recessive: OR = 2.67, CI = 1.53-4.64, p = 0.0005; allelic: OR = 1.75, CI = 1.32-2.30, p = 0.0001 and for CYP2E1 rs2070673, additive model 2: OR = 0.39, CI = 0.22-0.69, p = 0.0013; recessive: OR = 0.45, CI = 0.29-0.68, p = 0.0002; overdominant: OR = 1.49, CI = 1.02-2.19, p = 0.0408; allelic: OR = 0.61, CI = 0.46-0.80, p = 0.0004).
Conclusions: The findings of our study suggest that the polymorphisms NOTCH4 rs204993 and CYP2E1 rs2070673 in the Bangladeshi ethnicity are connected to the risk of SCZ.
Keywords: CYP2E1; NOTCH4; PCR–RFLP; genotyping; schizophrenia.
© 2024 The Author(s). Health Science Reports published by Wiley Periodicals LLC.
Conflict of interest statement
The corresponding author, Prof. Mohammad Safiqul Islam, PhD, is a member of the editorial board, and he will not be involved in any stage of decision‐making for this manuscript. The other authors declare no conflicts of interest.
Figures

References
-
- Marzan S., Aziz M. A., and Islam M. S., “Association Between REELIN Gene Polymorphisms (rs7341475 and rs262355) and Risk of Schizophrenia: An Updated Meta‐Analysis,” Journal of Molecular Neuroscience 71, no. 4 (2021): 675–690. - PubMed
-
- Kavanagh D. H., Tansey K. E., O'Donovan M. C., and Owen M. J., “Schizophrenia Genetics: Emerging Themes for a Complex Disorder,” Molecular Psychiatry 20, no. 1 (2015): 72–76. - PubMed
-
- Halley L., Doherty M. K., Megson I. L., McNamara N., Gadja A., and Wei J., “Search for Schizophrenia Susceptibility Variants at the HLA‐DRB1 Locus Among a British Population,” Immunogenetics 65, no. 1 (2013): 1–7. - PubMed
-
- Masi G., Mucci M., and Pari C., “Children With Schizophrenia: Clinical Picture and Pharmacological Treatment,” CNS Drugs 20, no. 10 (2006): 841–866. - PubMed
-
- Nicolson R., “Lessons From Childhood‐Onset Schizophrenia,” Brain Research Reviews 31, no. 2–3 (2000): 147–156. - PubMed
LinkOut - more resources
Full Text Sources